InVivo Therapeutics Hldgs Corp (fka NVIVQ)

[pistol1p]

$3.00 pps sounds reasonable to me, I guess we will just have to find investors willing to pay $3/share for NVIV.

I currently have a fair amount of money in NVIV, and if the technology works and SCI patients start to recover using the NVIV scaffold treatment, then we should easily see $3.00 and a lot more.

We may see more investors take a chance on NVIV, since the upside is great and the downside is somewhat limited, so the pps might continue to move upward.

I am holding my shares waiting for the patient enrollments to start and outcome data to be released.